| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/01/1994 | EP0599141A2 Means and process for immunological determination of amiodarone and its metabolites |
| 06/01/1994 | EP0598998A2 Humanized antibodies reacting with the ganglioside GM2 |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0598792A1 Osteoclast growth regulatory factor |
| 06/01/1994 | EP0598717A1 Duplex printer |
| 06/01/1994 | EP0555418A4 Peptide binding assays with mhc antigens |
| 06/01/1994 | EP0511202B1 A cell surface antigen associated with cellular apoptosis |
| 06/01/1994 | EP0483143B1 Membrane affinity apparatus and purification methods related thereto |
| 06/01/1994 | EP0439458B1 Characterization and detection of sequences associated with autoimmune diseases |
| 06/01/1994 | EP0172865B2 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
| 06/01/1994 | DE4239817A1 New protein tyrosine kinase and related nucleic acid - vectors, transformed cells, etc., useful for diagnosis and treatment of tumours |
| 05/31/1994 | US5317096 Transformation vectors allowing expression of foreign polypeptide endotoxins from Bacillus thuringiensis in plants |
| 05/31/1994 | US5317092 Protein purification method |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
| 05/31/1994 | US5317087 Interleukin 2-receptor protein precipitates, monoclonal antibodies |
| 05/31/1994 | US5317085 Polypeptides for genetic engineering |
| 05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| 05/31/1994 | US5316938 Defined media for serum-free tissue culture |
| 05/31/1994 | US5316937 Conditioned medium useful for sustaining growth of colonic crypt cells |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | US5316910 Bioassay for influenza A and B nucleoprotein |
| 05/31/1994 | US5316754 In vitro assay of mesangial cell-derived receptors for advanced glycosylation endproducts |
| 05/27/1994 | CA2102034A1 Antibody and method for its production |
| 05/26/1994 | WO1994011739A1 Diagnosis of eye disorders |
| 05/26/1994 | WO1994011738A1 Determination of peptide motifs on mhc molecules |
| 05/26/1994 | WO1994011533A1 METHODS FOR DETERMINING THE PRESENCE OF FUNCTIONAL p53 IN MAMMALIAN CELLS |
| 05/26/1994 | WO1994011523A2 Fully impaired consensus kozac sequences for mammalian expression |
| 05/26/1994 | WO1994011514A1 Human endogenous retrovirus-k-envelope-gene encoded glycoprotein, and a monoclonal antibody for diagnostic and therapeutic purposes |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011508A2 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 05/26/1994 | WO1994011507A2 Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011502A2 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011495A1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 05/26/1994 | WO1994011490A2 Products of the inhibition of advanced glycosylation |
| 05/26/1994 | WO1994011405A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/26/1994 | WO1994011404A1 Antibodies for gm-csf receptor and uses thereof |
| 05/26/1994 | WO1994011403A1 Artificial antibodies, method of producing the same and use thereof |
| 05/26/1994 | WO1994011389A1 Biological mediators of immune functions |
| 05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
| 05/26/1994 | WO1994011348A1 Detection of hypoxia |
| 05/26/1994 | WO1994011339A1 Substituted cyclopentane compounds for use as chelating agents |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011028A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011019A1 Materials and methods for immunocontraception |
| 05/26/1994 | WO1994010980A1 Compositions using microencapsulated neutralizing antibodies |
| 05/26/1994 | WO1994009805A3 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149881A1 Antibodies for gm-csf receptor and uses thereof |
| 05/26/1994 | CA2149043A1 Artificial antibodies, method of producing the same and use thereof |
| 05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
| 05/26/1994 | CA2147600A1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 05/26/1994 | CA2127531A1 Materials and methods for immunocontraception |
| 05/26/1994 | CA2126690A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/25/1994 | EP0598329A2 Simultaneous determination of HbA1c and haemoglobin variants with a HbA1c analog glycation |
| 05/25/1994 | EP0598108A1 Rabbit single domain antibody and use thereof |
| 05/25/1994 | EP0598000A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 05/25/1994 | EP0597960A1 Treatment of cell populations |
| 05/25/1994 | EP0597847A1 Synthetic senescent cell antigen |
| 05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 05/25/1994 | EP0597842A1 Metal binding proteins |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0252146B1 Nuclear factors associated with transcriptional regulation |
| 05/25/1994 | CA2109644A1 Agent and method for the immunological determination of amiodarone and its metabolites |
| 05/25/1994 | CA2103323A1 Her4 human receptor tyrosine kinase |
| 05/24/1994 | US5314996 Isolated nucleotide sequences encoding an: antigen binding site of monoclonal antibody PD41; and antigen associated with prostate adenocarcinomas |
| 05/24/1994 | US5314995 Antitumor |
| 05/24/1994 | US5314994 Inhibitor of tissue-type and urokinase-type plasminogen activators |
| 05/24/1994 | US5314817 Catalytic and reactive polypeptides and methods for their preparation and use |
| 05/24/1994 | US5314800 Purified human cytomegalovirus protein |
| 05/24/1994 | US5314642 Hydrolysis |
| 05/19/1994 | DE4238766A1 New inter-species antibodies reactive with cellular antigens - present in all mammals and birds under conditions of stress, useful for treating, preventing or diagnosing e.g. tumours or virus diseases |
| 05/19/1994 | DE4238416A1 Bestimmung von Peptidmotiven auf MHC-Molekülen Determination of peptide motifs on MHC molecules |
| 05/18/1994 | EP0597101A1 Stabilized human monoclonal antibody preparation |
| 05/18/1994 | EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 05/18/1994 | EP0597034A1 Haptens, tracers, immunogens and antibodies for immunoassays for propoxyphene |
| 05/18/1994 | EP0335899B1 Immunoaffinity purification system |
| 05/18/1994 | CA2103318A1 Simultaneous determination of hba1 and haemoglobin variants with a glycation analogous to hba1 |
| 05/17/1994 | US5312902 Dimer of the precursor of HIV-2 envelope glycoprotein |
| 05/17/1994 | US5312810 Adenylate cyclase stimulating factor |
| 05/17/1994 | US5312752 Specific antibodies against the DNA-binding domain of and immunoassays to determine the presence and functional status of estrogen receptor proteins |
| 05/17/1994 | US5312751 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis |
| 05/17/1994 | US5312733 Developmental marker gene of CD4-CD8 thymocytes |
| 05/17/1994 | CA1329546C Method for reperfusion therapy |
| 05/17/1994 | CA1329545C Immunological complex, its preparation and its use |
| 05/17/1994 | CA1329544C Galenic forms of allergens for sublingual administration |
| 05/13/1994 | CA2102848A1 Altered affinity polypeptides of metal chelate binding antibodies |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994010333A1 Crf binding protein |
| 05/11/1994 | WO1994010332A1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES |
| 05/11/1994 | WO1994010331A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | WO1994010323A1 Virus with modified binding moiety specific for the target cells |
| 05/11/1994 | WO1994010313A2 Interferon tau compositions and methods of use |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |